Literature DB >> 19514998

Liposome triggering of innate immune responses: a perspective on benefits and adverse reactions.

Janos Szebeni1, Seyed Moein Moghimi.   

Abstract

This commentary focuses on therapeutic advantages as well as adverse reactions that entail liposome triggering of the innate immune system, notably the complement cascade and macrophage clearance mechanisms. Our discussion is centered on macrophage drug delivery, evasion of macrophage surveillance, immunogenicity, and hypersensitivity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19514998     DOI: 10.1080/08982100902792855

Source DB:  PubMed          Journal:  J Liposome Res        ISSN: 0898-2104            Impact factor:   3.648


  23 in total

1.  Mechanism and efficacy of sub-50-nm tenfibgen nanocapsules for cancer cell-directed delivery of anti-CK2 RNAi to primary and metastatic squamous cell carcinoma.

Authors:  Gretchen M Unger; Betsy T Kren; Vicci L Korman; Tyler G Kimbrough; Rachel I Vogel; Frank G Ondrey; Janeen H Trembley; Khalil Ahmed
Journal:  Mol Cancer Ther       Date:  2014-05-27       Impact factor: 6.261

2.  Dual-responsive nanoparticles loading bevacizumab and gefitinib for molecular targeted therapy against non-small cell lung cancer.

Authors:  Zi-Tong Zhao; Jue Wang; Lei Fang; Xin-di Qian; Ying Cai; Hai-Qiang Cao; Guan-Ru Wang; Mei-Lin He; Yan-Yan Jiang; Dang-Ge Wang; Ya-Ping Li
Journal:  Acta Pharmacol Sin       Date:  2022-06-15       Impact factor: 6.150

3.  Mediation of a non-proteolytic activation of complement component C3 by phospholipid vesicles.

Authors:  Yvonne Klapper; Osama A Hamad; Yuji Teramura; Gero Leneweit; G Ulrich Nienhaus; Daniel Ricklin; John D Lambris; Kristina N Ekdahl; Bo Nilsson
Journal:  Biomaterials       Date:  2014-01-23       Impact factor: 12.479

Review 4.  Exosomes as natural delivery carriers for programmable therapeutic nucleic acid nanoparticles (NANPs).

Authors:  Weina Ke; Kirill A Afonin
Journal:  Adv Drug Deliv Rev       Date:  2021-06-16       Impact factor: 17.873

Review 5.  Improving In Vivo Efficacy of Bioactive Molecules: An Overview of Potentially Antitumor Phytochemicals and Currently Available Lipid-Based Delivery Systems.

Authors:  Lamia Mouhid; Marta Corzo-Martínez; Carlos Torres; Luis Vázquez; Guillermo Reglero; Tiziana Fornari; Ana Ramírez de Molina
Journal:  J Oncol       Date:  2017-05-07       Impact factor: 4.375

6.  Route and Type of Formulation Administered Influences the Absorption and Disposition of Vitamin B12 Levels in Serum.

Authors:  Luis Vitetta; Joyce Zhou; Rachel Manuel; Serena Dal Forno; Sean Hall; David Rutolo
Journal:  J Funct Biomater       Date:  2018-01-21

7.  Recent trends in multifunctional liposomal nanocarriers for enhanced tumor targeting.

Authors:  Federico Perche; Vladimir P Torchilin
Journal:  J Drug Deliv       Date:  2013-03-07

Review 8.  Advances and Challenges of Liposome Assisted Drug Delivery.

Authors:  Lisa Sercombe; Tejaswi Veerati; Fatemeh Moheimani; Sherry Y Wu; Anil K Sood; Susan Hua
Journal:  Front Pharmacol       Date:  2015-12-01       Impact factor: 5.810

9.  Phototriggerable liposomes: current research and future perspectives.

Authors:  Anu Puri
Journal:  Pharmaceutics       Date:  2013-12-19       Impact factor: 6.321

Review 10.  Nanoparticles for imaging, sensing, and therapeutic intervention.

Authors:  Lara K Bogart; Genevieve Pourroy; Catherine J Murphy; Victor Puntes; Teresa Pellegrino; Daniel Rosenblum; Dan Peer; Raphaël Lévy
Journal:  ACS Nano       Date:  2014-03-18       Impact factor: 15.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.